Do analysts recommend SINT or PETV?

Sintx Technologies presently has a consensus price target of $9.33, indicating a potential upside of 418.52%. Given Sintx Technologies' stronger consensus rating and higher possible upside, equities analysts plainly believe Sintx Technologies is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sintx Technologies 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is SINT or PETV more profitable?

Sintx Technologies has a net margin of -848.20% compared to PetVivo's net margin of -902.82%. Sintx Technologies' return on equity of -354.44% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets Sintx Technologies -848.20% -354.44% -115.37% PetVivo -902.82% -4,813.07% -281.78%

Does the media refer more to SINT or PETV?

In the previous week, Sintx Technologies had 1 more articles in the media than PetVivo. MarketBeat recorded 2 mentions for Sintx Technologies and 1 mentions for PetVivo. Sintx Technologies' average media sentiment score of 0.93 beat PetVivo's score of 0.00 indicating that Sintx Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sintx Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is FEMY or SINT more profitable?

Femasys has a net margin of -534.36% compared to Sintx Technologies' net margin of -848.20%. Femasys' return on equity of -225.97% beat Sintx Technologies' return on equity. Company Net Margins Return on Equity Return on Assets Femasys -534.36% -225.97% -74.68% Sintx Technologies -848.20% -354.44% -115.37%

Does the media prefer FEMY or SINT?

In the previous week, Femasys had 2 more articles in the media than Sintx Technologies. MarketBeat recorded 4 mentions for Femasys and 2 mentions for Sintx Technologies. Sintx Technologies' average media sentiment score of 0.93 beat Femasys' score of 0.63 indicating that Sintx Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Femasys 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sintx Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is SINT or BEAT more profitable?

HeartBeam has a net margin of 0.00% compared to Sintx Technologies' net margin of -848.20%. Sintx Technologies' return on equity of -354.44% beat HeartBeam's return on equity. Company Net Margins Return on Equity Return on Assets Sintx Technologies -848.20% -354.44% -115.37% HeartBeam N/A -686.78% -348.65%

Does the media favor SINT or BEAT?

In the previous week, Sintx Technologies and Sintx Technologies both had 2 articles in the media. Sintx Technologies' average media sentiment score of 0.93 equaled HeartBeam'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sintx Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HeartBeam 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer CTSO or SINT?

In the previous week, Cytosorbents had 4 more articles in the media than Sintx Technologies. MarketBeat recorded 6 mentions for Cytosorbents and 2 mentions for Sintx Technologies. Cytosorbents' average media sentiment score of 1.29 beat Sintx Technologies' score of 0.93 indicating that Cytosorbents is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cytosorbents 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sintx Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is LFWD or SINT more profitable?

Lifeward has a net margin of -141.28% compared to Sintx Technologies' net margin of -848.20%. Lifeward's return on equity of -235.86% beat Sintx Technologies' return on equity. Company Net Margins Return on Equity Return on Assets Lifeward -141.28% -235.86% -81.72% Sintx Technologies -848.20% -354.44% -115.37%

Does the media refer more to LFWD or SINT?

In the previous week, Lifeward and Lifeward both had 2 articles in the media. Lifeward's average media sentiment score of 0.93 equaled Sintx Technologies'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lifeward 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sintx Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Sintx Technologies (SINT) Competitors

$1.80 -0.06 (-3.23%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$1.80 -0.01 (-0.28%)

As of 09/11/2026 07:35 PM Eastern

Compare

SINT vs. PETV, FEMY, BEAT, CTSO, and LFWD

Should you buy Sintx Technologies stock or one of its competitors? Sintx Technologies's main competitors and comparable companies include PetVivo (PETV), Femasys (FEMY), HeartBeam (BEAT), Cytosorbents (CTSO), and Lifeward (LFWD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Sintx Technologies compare to PetVivo?

Sintx Technologies (NASDAQ:SINT) and PetVivo (NASDAQ:PETV) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, profitability and media sentiment.

18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 24.5% of PetVivo shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by company insiders. Comparatively, 10.8% of PetVivo shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Sintx Technologies had 1 more articles in the media than PetVivo. MarketBeat recorded 2 mentions for Sintx Technologies and 1 mentions for PetVivo. Sintx Technologies' average media sentiment score of 0.93 beat PetVivo's score of 0.00 indicating that Sintx Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sintx Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Sintx Technologies presently has a consensus price target of $9.33, indicating a potential upside of 418.52%. Given Sintx Technologies' stronger consensus rating and higher possible upside, equities analysts plainly believe Sintx Technologies is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Sintx Technologies has higher earnings, but lower revenue than PetVivo. PetVivo is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sintx Technologies	$1.02M	7.62	-$10.36M	-$4.91	N/A
PetVivo	$1.05M	24.69	-$10.95M	-$0.34	N/A

Sintx Technologies has a net margin of -848.20% compared to PetVivo's net margin of -902.82%. Sintx Technologies' return on equity of -354.44% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-848.20%	-354.44%	-115.37%
PetVivo	-902.82%	-4,813.07%	-281.78%

Summary

Sintx Technologies beats PetVivo on 10 of the 15 factors compared between the two stocks.

How does Sintx Technologies compare to Femasys?

Femasys (NASDAQ:FEMY) and Sintx Technologies (NASDAQ:SINT) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

Femasys has a net margin of -534.36% compared to Sintx Technologies' net margin of -848.20%. Femasys' return on equity of -225.97% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Femasys	-534.36%	-225.97%	-74.68%
Sintx Technologies	-848.20%	-354.44%	-115.37%

Sintx Technologies has lower revenue, but higher earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Femasys	$2.29M	10.17	-$18.63M	-$3.53	N/A
Sintx Technologies	$1.02M	7.62	-$10.36M	-$4.91	N/A

65.3% of Femasys shares are owned by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are owned by institutional investors. 7.8% of Femasys shares are owned by company insiders. Comparatively, 4.1% of Sintx Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Femasys currently has a consensus price target of $50.00, suggesting a potential upside of 1,698.56%. Sintx Technologies has a consensus price target of $9.33, suggesting a potential upside of 418.52%. Given Femasys' higher probable upside, equities analysts clearly believe Femasys is more favorable than Sintx Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Femasys had 2 more articles in the media than Sintx Technologies. MarketBeat recorded 4 mentions for Femasys and 2 mentions for Sintx Technologies. Sintx Technologies' average media sentiment score of 0.93 beat Femasys' score of 0.63 indicating that Sintx Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Femasys	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sintx Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Femasys beats Sintx Technologies on 10 of the 13 factors compared between the two stocks.

How does Sintx Technologies compare to HeartBeam?

Sintx Technologies (NASDAQ:SINT) and HeartBeam (NASDAQ:BEAT) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation.

HeartBeam has a net margin of 0.00% compared to Sintx Technologies' net margin of -848.20%. Sintx Technologies' return on equity of -354.44% beat HeartBeam's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-848.20%	-354.44%	-115.37%
HeartBeam	N/A	-686.78%	-348.65%

Sintx Technologies has higher revenue and earnings than HeartBeam. HeartBeam is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sintx Technologies	$1.02M	7.62	-$10.36M	-$4.91	N/A
HeartBeam	N/A	N/A	-$21.01M	-$0.51	N/A

Sintx Technologies presently has a consensus price target of $9.33, indicating a potential upside of 418.52%. HeartBeam has a consensus price target of $4.00, indicating a potential upside of 884.25%. Given HeartBeam's stronger consensus rating and higher probable upside, analysts clearly believe HeartBeam is more favorable than Sintx Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
HeartBeam	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.67

18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 7.8% of HeartBeam shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by company insiders. Comparatively, 18.0% of HeartBeam shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Sintx Technologies and Sintx Technologies both had 2 articles in the media. Sintx Technologies' average media sentiment score of 0.93 equaled HeartBeam'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sintx Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HeartBeam	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

HeartBeam beats Sintx Technologies on 7 of the 13 factors compared between the two stocks.

How does Sintx Technologies compare to Cytosorbents?

Cytosorbents (NASDAQ:CTSO) and Sintx Technologies (NASDAQ:SINT) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

In the previous week, Cytosorbents had 4 more articles in the media than Sintx Technologies. MarketBeat recorded 6 mentions for Cytosorbents and 2 mentions for Sintx Technologies. Cytosorbents' average media sentiment score of 1.29 beat Sintx Technologies' score of 0.93 indicating that Cytosorbents is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cytosorbents	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sintx Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cytosorbents has higher revenue and earnings than Sintx Technologies. Cytosorbents is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cytosorbents	$37.22M	0.54	-$8.20M	-$5.80	N/A
Sintx Technologies	$1.02M	7.62	-$10.36M	-$4.91	N/A

Cytosorbents presently has a consensus target price of $107.50, indicating a potential upside of 1,577.07%. Sintx Technologies has a consensus target price of $9.33, indicating a potential upside of 418.52%. Given Cytosorbents' higher possible upside, equities research analysts clearly believe Cytosorbents is more favorable than Sintx Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cytosorbents	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

32.9% of Cytosorbents shares are held by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are held by institutional investors. 7.8% of Cytosorbents shares are held by insiders. Comparatively, 4.1% of Sintx Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Cytosorbents has a net margin of -48.94% compared to Sintx Technologies' net margin of -848.20%. Sintx Technologies' return on equity of -354.44% beat Cytosorbents' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cytosorbents	-48.94%	-431.65%	-41.94%
Sintx Technologies	-848.20%	-354.44%	-115.37%

Summary

Cytosorbents beats Sintx Technologies on 9 of the 15 factors compared between the two stocks.

How does Sintx Technologies compare to Lifeward?

Lifeward (NASDAQ:LFWD) and Sintx Technologies (NASDAQ:SINT) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings, media sentiment and valuation.

Lifeward has a net margin of -141.28% compared to Sintx Technologies' net margin of -848.20%. Lifeward's return on equity of -235.86% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifeward	-141.28%	-235.86%	-81.72%
Sintx Technologies	-848.20%	-354.44%	-115.37%

In the previous week, Lifeward and Lifeward both had 2 articles in the media. Lifeward's average media sentiment score of 0.93 equaled Sintx Technologies'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lifeward	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sintx Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Lifeward currently has a consensus price target of $10.00, indicating a potential upside of 38.29%. Sintx Technologies has a consensus price target of $9.33, indicating a potential upside of 418.52%. Given Sintx Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Sintx Technologies is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifeward	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

26.8% of Lifeward shares are owned by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are owned by institutional investors. 1.5% of Lifeward shares are owned by insiders. Comparatively, 4.1% of Sintx Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Sintx Technologies has lower revenue, but higher earnings than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifeward	$22.03M	0.93	-$19.91M	-$16.82	N/A
Sintx Technologies	$1.02M	7.62	-$10.36M	-$4.91	N/A

Summary

Sintx Technologies beats Lifeward on 8 of the 13 factors compared between the two stocks.

Get Sintx Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SINT vs. The Competition

Export

Metric	Sintx Technologies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$5.48B	$7.15B	$12.85B
Dividend Yield	N/A	1.80%	2.57%	11.17%
P/E Ratio	-0.37	25.09	274.94	25.36
Price / Sales	7.62	71.54	686.57	116.78
Price / Cash	N/A	32.57	76.65	51.52
Price / Book	2.25	5.97	10.33	6.20
Net Income	-$10.36M	$150.75M	$3.50B	$358.50M
7 Day Performance	10.43%	-2.83%	-3.32%	-2.35%
1 Month Performance	5.26%	-3.73%	-0.53%	-3.23%
1 Year Performance	-58.62%	9.38%	23.51%	8.79%

Sintx Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SINT Sintx Technologies	1.9049 of 5 stars	$1.80 -3.2%	$9.33 +418.5%	-58.6%	$0.00	$1.02M	N/A	40	High Trading Volume
PETV PetVivo	N/A	$0.66 -2.9%	N/A	-24.4%	$25.05M	$1.05M	N/A	20
FEMY Femasys	3.603 of 5 stars	$2.68 -10.1%	$50.00 +1,765.7%	-64.5%	$24.96M	$2.29M	N/A	30	Gap Up
BEAT HeartBeam	3.0172 of 5 stars	$0.45 +4.3%	$4.00 +798.3%	-71.5%	$24.05M	N/A	N/A	1,700	News Coverage Gap Up
CTSO Cytosorbents	2.428 of 5 stars	$6.85 -2.2%	$107.50 +1,469.3%	-65.8%	$22.06M	$37.06M	N/A	220	News Coverage Positive News Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SINT) was last updated on 9/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sintx Technologies (SINT) Competitors

SINT vs. PETV, FEMY, BEAT, CTSO, and LFWD

How does Sintx Technologies compare to PetVivo?

Summary

How does Sintx Technologies compare to Femasys?

Summary

How does Sintx Technologies compare to HeartBeam?

Summary

How does Sintx Technologies compare to Cytosorbents?

Summary

How does Sintx Technologies compare to Lifeward?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SINT vs. The Competition

Sintx Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sintx Technologies (SINT) Competitors

SINT vs. PETV, FEMY, BEAT, CTSO, and LFWD

How does Sintx Technologies compare to PetVivo?

Do insiders and institutionals believe in SINT or PETV?

Does the media refer more to SINT or PETV?

Do analysts recommend SINT or PETV?

Which has better valuation and earnings, SINT or PETV?

Is SINT or PETV more profitable?

Summary

How does Sintx Technologies compare to Femasys?

Is FEMY or SINT more profitable?

Which has higher valuation & earnings, FEMY or SINT?

Do insiders and institutionals hold more shares of FEMY or SINT?

Do analysts prefer FEMY or SINT?

Does the media prefer FEMY or SINT?

Summary

How does Sintx Technologies compare to HeartBeam?

Is SINT or BEAT more profitable?

Which has preferable valuation & earnings, SINT or BEAT?

Do analysts prefer SINT or BEAT?

Do insiders & institutionals have more ownership in SINT or BEAT?

Does the media favor SINT or BEAT?

Summary

How does Sintx Technologies compare to Cytosorbents?

Does the media prefer CTSO or SINT?

Which has preferable valuation and earnings, CTSO or SINT?

Do analysts rate CTSO or SINT?

Do insiders and institutionals believe in CTSO or SINT?

Is CTSO or SINT more profitable?

Summary

How does Sintx Technologies compare to Lifeward?

Is LFWD or SINT more profitable?

Does the media refer more to LFWD or SINT?

Do analysts prefer LFWD or SINT?

Do insiders & institutionals believe in LFWD or SINT?

Which has stronger earnings and valuation, LFWD or SINT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SINT vs. The Competition

Sintx Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools